Topic
Clinical Trials
3 posts
SAVA Stock Rebrand & Forecast: Is Filana Therapeutics (FLNA) a Buy?
Looking for SAVA stock news? Cassava Sciences has officially rebranded as Filana Therapeutics (FLNA). Read our deep dive into the pivot, trials, and forecast.
May 25, 2026·14 min read
AVCT Stock: Avacta LSE Clinical Growth vs. AVCTQ Legacy Case
Wondering what is happening with AVCT stock? Learn about Avacta Group PLC (LSE: AVCT) 2026 clinical breakthroughs and the final status of AVCTQ bankruptcy.
May 25, 2026·12 min read
VXRT Stock: Is Vaxart a Buy Ahead of Pivotal 2026 Catalysts?
Discover if Vaxart (VXRT stock) is a buy or sell in 2026. Get deep insights into clinical updates, the Dynavax deal, and OTCQX market performance.
May 24, 2026·15 min read